Increasingly payers and providers are hearing more about AI in precision medicine. But not all AI is alike. The saturation of AI “can make people sour on the field as a whole, so it is good to vet the accuracy of claims and ask organizations if they have any data that can validate their claims,”… Read more »
Read technology and industry insights from Interpreta's healthcare experts.
Learn how Interpreta is helping clinicians, care managers, and health plans to orchestrate and advance quality healthcare using real-time analysis to synchronize healthcare.
Media contact: Merritt Carverinfo@interpreta.com
Many are predicting the future of healthcare will involve constant interpreting and analyzing large reservoirs of data, or “omics” as they are commonly known. ClinicalOMICs recently looked for the hottest, most advanced companies in the omics space that are delivering molecular and precision medicine for patients today. Interpreta is happy to be recognized as a… Read more »READ MORE »
Increasingly, artificial intelligence (AI), machine learning (ML), and deep learning (DL) are gaining traction in financial markets, big data analytics, and consumer devices. But how will AI growth intersect with healthcare in the coming year? Interpreta’s Vice President, Medical Informatics and Genomics, Benjamin Yu, MD PhD, discusses the opportunities and challenges for healthcare executives in implementing… Read more »READ MORE »
Imagine if, in between picking up aspirin and finding a birthday card at the pharmacy, you could have basic biometrics data taken to automatically inform medication dosage and other care decisions by your doctor. It’s already starting to happen, and also includes analyzing your genome alongside that biometric and clinical data. A partnership between Interpreta… Read more »READ MORE »
Now that the cost for sequencing an entire genome has fallen under $1000, it’s likely that EHRs will soon need to interpret whole or partial genomes. EHRs and CDS systems will need to be smart about analyzing relevant genetic variant information when there is a change in the patient’s medical history or if new genetic guidance is… Read more »READ MORE »